Bank of New York Mellon Corp - DEXCOM INC ownership

DEXCOM INC's ticker is and the CUSIP is 252131AK3. A total of 71 filers reported holding DEXCOM INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of DEXCOM INC
ValueSharesWeighting
Q3 2023$661,535
-11.5%
700,0000.0%0.00%
Q2 2023$747,656
-23.7%
700,000
-22.2%
0.00%
Q4 2022$980,100
-30.0%
900,000
-40.3%
0.00%
Q3 2022$1,401,000
+39.1%
1,508,000
+37.1%
0.00%
Q2 2022$1,007,000
-20.2%
1,100,0000.0%0.00%
Q1 2022$1,262,000
-49.4%
1,100,000
-47.6%
0.00%
Q4 2021$2,494,000
+61.7%
2,100,000
+61.5%
0.00%
Q3 2021$1,542,000
+47.4%
1,300,000
+30.0%
0.00%
Q2 2021$1,046,0001,000,0000.00%
Other shareholders
DEXCOM INC shareholders Q4 2022
NameSharesValueWeighting ↓
PIER 88 INVESTMENT PARTNERS LLC 17,495,000$16,120,0003.83%
SSI INVESTMENT MANAGEMENT LLC 34,177,000$31,482,0002.11%
Liberty Mutual Group Asset Management Inc. 4,075,000$3,754,0001.13%
ADVENT CAPITAL MANAGEMENT /DE/ 64,568,000$59,806,0001.08%
MACKAY SHIELDS LLC 43,555,000$40,304,0001.02%
SHENKMAN CAPITAL MANAGEMENT INC 18,523,000$17,071,0000.96%
ZAZOVE ASSOCIATES LLC 9,022,000$8,360,0000.76%
GOLDMAN SACHS GROUP INC 29,515,000$2,719,069,0000.63%
Calamos Advisors LLC 66,187,000$61,330,0000.28%
RWC Asset Management LLP 6,000,000$5,566,0000.19%
View complete list of DEXCOM INC shareholders